Nea Management Company, LLC Verona Pharma PLC Transaction History
Nea Management Company, LLC
- $1.6 Billion
- Q3 2025
A detailed history of Nea Management Company, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 2,252,994 shares of VRNA stock, worth $241 Million. This represents 15.02% of its overall portfolio holdings.
Number of Shares
2,252,994
Previous 2,263,138
0.45%
Holding current value
$241 Million
Previous $214 Million
12.29%
% of portfolio
15.02%
Previous 17.75%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
273Shares Held
76.9MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...